Cyclin-Dependent Kinase 4/6 Inhibitors in Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer: Efficacy, Safety, and Clinical Integration. Cuestiones de Fisioterapia, [S. l.], v. 53, n. 03, p. 6759–6769, 2024. DOI: 10.48047/xjqvkf88. Disponível em: https://cuestionesdefisioterapia.com/index.php/es/article/view/3925.. Acesso em: 5 jul. 2026.